PTO- 1957 |
Approved for use through 11/30/2023. OMB 0651-0050 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
90302923 |
LAW OFFICE ASSIGNED |
LAW OFFICE 104 |
MARK SECTION |
MARK |
mark |
LITERAL ELEMENT |
EUROAPI |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
GOODS AND/OR SERVICES SECTION (001) (current) |
INTERNATIONAL CLASS |
001 |
DESCRIPTION |
Chemical products for use in industry and science |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
GOODS AND/OR SERVICES SECTION (001) (proposed) |
INTERNATIONAL CLASS |
001 |
TRACKED TEXT DESCRIPTION |
Chemical products for use in industry and science; Chemicals for
use in industry and science |
FINAL DESCRIPTION |
Chemicals for use in industry and science |
WEBPAGE URL |
None Provided |
WEBPAGE DATE OF ACCESS |
None Provided |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
INTENT TO
PERFECT 44(d)
|
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await
the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
GOODS AND/OR SERVICES SECTION (005) (current) |
INTERNATIONAL CLASS |
005 |
DESCRIPTION |
Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory
diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune
diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use; bacterial
preparations for medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for
veterinary and medical use; food supplements for human beings and animals; disinfectants |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
GOODS AND/OR SERVICES SECTION (005) (proposed) |
INTERNATIONAL CLASS |
005 |
TRACKED TEXT DESCRIPTION |
Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous
system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease,
dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases,
rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine
diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food
substances adapted for medical use; dietetic foods adapted for medical use; bacterial preparations for medical and veterinary
use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic
foods and beverages adapted for veterinary and medical use; food supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use |
FINAL DESCRIPTION |
Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory
diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune
diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for
medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical
use; food supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use |
WEBPAGE URL |
None Provided |
WEBPAGE DATE OF ACCESS |
None Provided |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
INTENT TO
PERFECT 44(d)
|
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await
the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
GOODS AND/OR SERVICES SECTION (040) (current) |
INTERNATIONAL CLASS |
040 |
DESCRIPTION |
Treatment of chemicals; biochemicals, namely, monoclonal antibodies for pharmaceutical use; Technical and scientific services, namely,
for the processing of chemicals in the field of pharmaceuticals |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
GOODS AND/OR SERVICES SECTION (040) (proposed) |
INTERNATIONAL CLASS |
040 |
TRACKED TEXT DESCRIPTION |
Treatment of chemicals; Treatment of chemicals, namely, custom
manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; biochemicals, namely, monoclonal antibodies for pharmaceutical
use; Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing; Technical and scientific services, namely, for the processing of chemicals in the field of pharmaceuticals |
FINAL DESCRIPTION |
Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients;
Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing |
WEBPAGE URL |
None Provided |
WEBPAGE DATE OF ACCESS |
None Provided |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
INTENT TO
PERFECT 44(d)
|
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await
the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
GOODS AND/OR SERVICES SECTION (042) (current) |
INTERNATIONAL CLASS |
042 |
DESCRIPTION |
Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new
active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of
analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting
and assistance in the field of chemical manufacturing and pharmaceuticals, including experimental and production processes and installations; scientific and technical services for auditing industrial
installations; research and development services in the field of pharmaceuticals; research and development services for chemicals for the products of third parties, namely, the scientific and
technical development of synthetic processes in the field of chemistry and biochemistry; research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and
industrial processes; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific
services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied research and development
services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical,
chemical or agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and
pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; management and licensing services of
industrial property rights and technology transfer matters; scientific and technological services, namely, consulting and assistance for the manufacture of chemicals and pharmaceuticals, including
experimental and production processes and installations; scientific and technical services, namely, auditing for industrial installations |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
GOODS AND/OR SERVICES SECTION (042) (proposed) |
INTERNATIONAL CLASS |
042 |
TRACKED TEXT DESCRIPTION |
Research and development services in the field of health and biotechnologies, namely, research in the area of the
development of new active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and
research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in
the field of chemical manufacturing and pharmaceuticals, including experimental and production processes and installations; Scientific and technological
services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific and technical services for auditing industrial
installations; scientific and technical services, namely, scientific analysis of industrial installations; research and
development services in the field of pharmaceuticals; scientific research and development services in the field of pharmaceuticals; research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and
biochemistry; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of
synthetic processes in the field of chemistry and biochemistry; research and scientific and technical development in the field of pharmaceutical, chemical,
agrochemical and industrial processes; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and
industrial processes; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial
processes; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied research and development services, namely, conception of development or commercial batches for third parties in the fields of
pharmaceuticals and chemicals; scientific and technological services, namely, applied scientific research and development services, namely, conception of
development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical,
chemical or agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in
the chemical and pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial
technology; management and licensing services of industrial property rights and technology transfer matters; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and
installations; scientific and technological services, namely, consulting and assistance for the manufacture of chemicals and pharmaceuticals, including
experimental and production processes and installations; scientific and technical services, namely, auditing for industrial installations |
FINAL DESCRIPTION |
Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new
active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of
analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting
and assistance in the research and development of pharmaceuticals; scientific and technical services, namely, scientific analysis of industrial installations; scientific research and development
services in the field of pharmaceuticals; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic
processes in the field of chemistry and biochemistry; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes;
scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific
analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied scientific research and development services, namely,
conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or
agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields;
engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; scientific and technological services, namely, consulting and
assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations |
WEBPAGE URL |
None Provided |
WEBPAGE DATE OF ACCESS |
None Provided |
FILING BASIS |
Section 1(b) |
FILING BASIS |
Section 44(d) |
FOREIGN APPLICATION NUMBER |
4692947 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
France |
FOREIGN FILING DATE |
10/19/2020 |
INTENT TO
PERFECT 44(d)
|
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await
the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
CORRESPONDENCE INFORMATION (current) |
NAME |
KAREN LIM |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
klim-docket@fzlz.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
SYN 2010687 |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Karen Lim |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
klim-docket@fzlz.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
SYN 2010687 |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/kl/ |
SIGNATORY'S NAME |
Lim, Karen |
SIGNATORY'S POSITION |
Attorney of record, New York bar member |
SIGNATORY'S PHONE NUMBER |
2128135900 |
DATE SIGNED |
02/11/2021 |
ROLE OF AUTHORIZED SIGNATORY |
Authorized U.S.-Licensed Attorney |
SIGNATURE METHOD |
Sent to third party for signature |
FILING INFORMATION SECTION |
SUBMIT DATE |
Thu Feb 11 14:00:46 ET 2021 |
TEAS STAMP |
USPTO/ROA-XX.XXX.XXX.XX-2
0210211140046067464-90302
923-7607281bc1fb0a748f5ff
911d89f16941d13d9b3d9e2b4
27aba8c042b13f395266-N/A-
N/A-20210211104801081852 |
PTO- 1957 |
Approved for use through 11/30/2023. OMB 0651-0050 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
90302923 EUROAPI(Standard Characters, see http://uspto.report/TM/90302923/mark.png) has been amended as follows:
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following:
Current:
Class 001 for Chemical products for use in industry and science
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate
control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services
to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the
applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section 1126(d), as amended.
Proposed:
Tracked Text Description: Chemical products for use in industry and science;
Chemicals for use in industry and
scienceClass 001 for Chemicals for use in industry and science
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Webpage URL: None Provided
Webpage Date of Access: None Provided
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise
legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the
goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the
applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section
1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Applicant proposes to amend the following:
Current:
Class 005 for Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases,
rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine
diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use; bacterial preparations for medical and veterinary use;
disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food supplements for
human beings and animals; disinfectants
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate
control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services
to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the
applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section 1126(d), as amended.
Proposed:
Tracked Text Description: Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory
diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune
diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases;
Pharmaceutical preparations for the treatment of
cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological
diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases;
hormones;
vitamins;
dietetic and food substances adapted for medical use;
dietetic foods adapted for medical use;
bacterial preparations for medical and veterinary use;
disinfectants for hygienic purposes;
medicated supplements for foodstuffs for medical or veterinary use;
dietetic foods and beverages adapted for veterinary and medical use;
food supplements for human beings and animals;
disinfectants;
biochemicals, namely, monoclonal antibodies for
pharmaceutical useClass 005 for Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer,
allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood
diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for medical and
veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food
supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Webpage URL: None Provided
Webpage Date of Access: None Provided
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise
legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the
goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the
applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section
1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Applicant proposes to amend the following:
Current:
Class 040 for Treatment of chemicals; biochemicals, namely, monoclonal antibodies for pharmaceutical use; Technical and scientific services, namely, for the processing of chemicals in the field of
pharmaceuticals
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate
control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services
to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the
applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section 1126(d), as amended.
Proposed:
Tracked Text Description: Treatment of chemicals;
Treatment of chemicals, namely, custom manufacture and custom synthesis of
pharmaceuticals and active pharmaceutical ingredients;
biochemicals, namely, monoclonal antibodies for pharmaceutical use;
Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing;
Technical and scientific
services, namely, for the processing of chemicals in the field of pharmaceuticalsClass 040 for Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and
active pharmaceutical ingredients; Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Webpage URL: None Provided
Webpage Date of Access: None Provided
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise
legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the
goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the
applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section
1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Applicant proposes to amend the following:
Current:
Class 042 for Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active elements; research in the area of a means of
synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and
bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in the field of chemical manufacturing
and pharmaceuticals, including experimental and production processes and installations; scientific and technical services for auditing industrial installations; research and development services in
the field of pharmaceuticals; research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field
of chemistry and biochemistry; research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific services, namely,
scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific analysis allowing the
identification and physical characterization of chemical molecules; scientific and technological services, namely, applied research and development services, namely, conception of development or
commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or agrochemical products; engineering
services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields; engineering services for chemical
and organic products and the processing thereof in the field of basic and industrial technology; management and licensing services of industrial property rights and technology transfer matters;
scientific and technological services, namely, consulting and assistance for the manufacture of chemicals and pharmaceuticals, including experimental and production processes and installations;
scientific and technical services, namely, auditing for industrial installations
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate
control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services
to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the
applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section 1126(d), as amended.
Proposed:
Tracked Text Description: Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active
elements;
research in the area of a means of synthesis in the field of pharmaceutical products;
scientific study and research in the area of
industrial quality;
development of methods of analysis for chemical and pharmaceutical products and bioorganics;
development and studies of
analytical methods checking chemical reactions;
Scientific and technological services, namely, consulting and assistance in the field of chemical manufacturing
and pharmaceuticals, including experimental and production processes and installations;
Scientific and technological services, namely, consulting and assistance
in the research and development of pharmaceuticals;
scientific and technical services for auditing industrial installations;
scientific and technical services, namely, scientific analysis of industrial installations;
research and development services in the field of
pharmaceuticals;
scientific research and development services in the field of pharmaceuticals;
research and development
services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry;
scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of
chemistry and biochemistry;
research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial
processes;
scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes;
scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes;
scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules;
scientific and technological services, namely, applied research and development services, namely, conception of development or commercial batches for third parties in the fields of
pharmaceuticals and chemicals;
scientific and technological services, namely, applied scientific research and development services, namely, conception of
development or commercial batches for third parties in the fields of pharmaceuticals and chemicals;
formulation and pre-formulation process design for pharmaceutical,
chemical or agrochemical products;
engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in
the chemical and pharmaceutical fields;
engineering services for chemical and organic products and the processing thereof in the field of basic and industrial
technology;
management and licensing services of industrial property rights and technology transfer matters;
scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and
installations;
scientific and technological services, namely, consulting and assistance for the manufacture of chemicals and pharmaceuticals, including
experimental and production processes and installations;
scientific and technical services, namely, auditing for industrial installationsClass 042 for
Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active elements; research in the area of a means of synthesis in
the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics;
development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals;
scientific and technical services, namely, scientific analysis of industrial installations; scientific research and development services in the field of pharmaceuticals; scientific research and
development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific
research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific services, namely, scientific research and industrial
analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific analysis allowing the identification and physical
characterization of chemical molecules; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches
for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or agrochemical products; engineering services, namely,
formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields; engineering services for chemical and organic
products and the processing thereof in the field of basic and industrial technology; scientific and technological services, namely, consulting and assistance in the research and development of
chemicals and pharmaceuticals, including experimental and production processes and installations
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Webpage URL: None Provided
Webpage Date of Access: None Provided
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide
intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application.
For a
collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to
exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority
based upon a foreign application.
For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise
legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the
goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the
applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ France application number 4692947 filed 10/19/2020]. 15 U.S.C.Section
1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Correspondence Information (current):
KAREN LIM
PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
The docket/reference number is SYN 2010687.
Correspondence Information (proposed):
Karen Lim
PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
The docket/reference number is SYN 2010687.
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
SIGNATURE(S)
Response Signature
Signature: /kl/ Date: 02/11/2021
Signatory's Name: Lim, Karen
Signatory's Position: Attorney of record, New York bar member
Signatory's Phone Number: 2128135900 Signature method: Sent to third party for signature
The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and
any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another
U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed
revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter;
or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.
Mailing Address: KAREN LIM
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
151 WEST 42ND STREET, 17TH FLOOR
NEW YORK, New York 10036
Mailing Address: Karen Lim
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
151 WEST 42ND STREET, 17TH FLOOR
NEW YORK, New York 10036
Serial Number: 90302923
Internet Transmission Date: Thu Feb 11 14:00:46 ET 2021
TEAS Stamp: USPTO/ROA-XX.XXX.XXX.XX-2021021114004606
7464-90302923-7607281bc1fb0a748f5ff911d8
9f16941d13d9b3d9e2b427aba8c042b13f395266
-N/A-N/A-20210211104801081852